Cargando…
MalDA, Accelerating Malaria Drug Discovery
The Malaria Drug Accelerator (MalDA) is a consortium of 15 leading scientific laboratories. The aim of MalDA is to improve and accelerate the early antimalarial drug discovery process by identifying new, essential, druggable targets. In addition, it seeks to produce early lead inhibitors that may be...
Autores principales: | Yang, Tuo, Ottilie, Sabine, Istvan, Eva S., Godinez-Macias, Karla P., Lukens, Amanda K., Baragaña, Beatriz, Campo, Brice, Walpole, Chris, Niles, Jacquin C., Chibale, Kelly, Dechering, Koen J., Llinás, Manuel, Lee, Marcus C.S., Kato, Nobutaka, Wyllie, Susan, McNamara, Case W., Gamo, Francisco Javier, Burrows, Jeremy, Fidock, David A., Goldberg, Daniel E., Gilbert, Ian H., Wirth, Dyann F., Winzeler, Elizabeth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261838/ https://www.ncbi.nlm.nih.gov/pubmed/33648890 http://dx.doi.org/10.1016/j.pt.2021.01.009 |
Ejemplares similares
-
Prioritization of Molecular Targets for Antimalarial Drug Discovery
por: Forte, Barbara, et al.
Publicado: (2021) -
Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug Discovery
por: Murithi, James M., et al.
Publicado: (2020) -
Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance
por: Mandt, Rebecca EK, et al.
Publicado: (2023) -
An Outbreak of Epidemic Dropsy at Malda Jail
por: Bhowmik, Basanta Kumar, et al.
Publicado: (1920) -
Chemogenomics identifies acetyl-coenzyme A synthetase as a target for malaria treatment and prevention
por: Summers, Robert L., et al.
Publicado: (2022)